Related Experiment Video
Updated: Dec 15, 2025

Laboratory Techniques Used to Maintain and Differentiate Biotypes of Vibrio cholerae Clinical and Environmental Isolates
Published on: May 30, 2017
Cholera and Pancreatic Cholera: Is VIP the Common Pathophysiologic Factor?
Farzana Afroze1, Steven Bloom2, Paul Bech2
1International Centre for Diarrheal Disease Research (icddr,b), Dhaka 1212, Bangladesh.
Vasoactive intestinal polypeptide (VIP) in stool, but not plasma, was significantly elevated in cholera patients. High stool VIP levels correlated with increased stool output and longer hospital stays, suggesting VIP plays a role in cholera severity.
Area of Science:
- Gastroenterology
- Infectious Diseases
- Molecular Medicine
Background:
- Cholera is a severe diarrheal disease causing dehydration and shock, particularly in developing nations.
- Vasoactive intestinal polypeptide (VIP) is known to mediate pancreatic cholera syndrome.
- The role of VIP in the pathophysiology of human cholera requires further investigation.
Purpose of the Study:
- To investigate the role of vasoactive intestinal polypeptide (VIP) in the pathophysiology of human cholera.
- To measure plasma and stool VIP levels in cholera patients and correlate them with clinical outcomes.
Main Methods:
- A prospective observational study was conducted on 23 cholera patients hospitalized with severe dehydration.
- Plasma and stool VIP levels were measured at multiple time points: admission, post-rehydration, and discharge.
- Multivariable Generalized Estimating Equation (GEE) models were used for statistical analysis.
Main Results:
- Stool VIP (sVIP) levels were significantly elevated in cholera patients compared to plasma VIP (pVIP) levels, which remained within the normal range.
- Elevated sVIP levels were consistently observed across all measured time points.
- Multivariable analysis revealed a significant association between higher sVIP levels and increased duration of hospitalization, total stool volume, and 24-hour stool output.
Conclusions:
- The findings suggest that VIP, released by intestinal nerves, plays a significant role in human cholera.
- Elevated stool VIP levels are linked to increased disease severity and duration.
- Inhibitors targeting intestinal VIP warrant investigation as potential therapeutic agents for cholera.
More Related Videos
Related Concept Videos
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Pathophysiology of Vomiting
GPCRs Regulate Adenylyl Cylase Activity
Acute Pancreatitis I: Introduction
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Pancreatic Juice and Secretion
When acidic chyme from the stomach enters the duodenum, it triggers the release of secretin, a hormone that prompts pancreatic juice secretion. After a fatty meal, cholecystokinin, another hormone, stimulates gallbladder contraction and enhances enzyme-rich...

